Catherine Rhee

机构：Harvard University, Massachusetts General Hospital, AstraZeneca (United States), Harvard Stem Cell Institute · ORCID：0000-0002-1613-1975

发表论文 57 篇 · 总被引 924 次 · h-index 14

代表论文

• Cell of origin epigenetic priming determines susceptibility to Tet2 mutation (2024 · Nature Communications · 被引 14)
• Clearing and replacing tissue-resident myeloid cells with an anti-CD45 antibody–drug conjugate (2023 · Blood Advances · 被引 11)
• Limited plasticity of monocyte fate and function associated with epigenetic scripting at the level of progenitors (2023 · Blood · 被引 11)
• Derepressing nuclear pyruvate dehydrogenase induces therapeutic cancer cell reprogramming (2025 · Cell Metabolism · 被引 8)
• Lymphoid origin of intrinsically activated plasmacytoid dendritic cells in mice (2024 · eLife · 被引 6)
• Abstract A040: Resistance to trastuzumab deruxtecan acquired through multifaceted pathway alterations in preclinical models (2025 · Molecular Cancer Therapeutics · 被引 1)